Ads
related to: benadryl in india for coronavirus prevention study chart printable version
Search results
Results From The WOW.Com Content Network
Diphenhydramine, sold under the brand name Benadryl among others, is an antihistamine and sedative.It is a first-generation H 1-antihistamine and it works by blocking certain effects of histamine, which produces its antihistamine and sedative effects.
Benadryl Dry, Tickly Cough Liquid is a cough medicine found in Australia. It is used to temporarily relieve irritating coughs. Pholcodine is the main ingredient found in this cough liquid. [11] This medication is to be taken orally and may cause drowsiness. In India, Benadryl can also be found in the form of a cough liquid and also cough lozenges.
Building on past research, a study conducted by the Indiana University School of Medicine suggests anticholinergic drugs of both the over-the-counter and prescription varieties are linked to ...
In India, the Sominex name is used by Lunar BioPharma Pvt. Ltd. to market a nutritional supplement intended to provide gastrointestinal relief. [9] This version of Sominex is unrelated to the US and UK formulations; [ citation needed ] however, the US version repackaged by Navajo Manufacturing Co., Inc. is sold through GNH India.
The first cases of COVID-19 in India were reported on 30 January 2020 in three towns of Kerala, among three Indian medical students who had returned from Wuhan, the epicenter of the pandemic. [10] [11] [12] Lockdowns were announced in Kerala on 23 March, and in the rest of the country on 25 March. Infection rates started to drop in September. [13]
The National Centre for Disease Informatics and Research, ICMR, released a document titled "Guidance for appropriate recording of COVID-19 related deaths in India". [2] In March 2020, the first two COVID-19 infected people to die in India officially died due to their co-morbidities and not COVID-19. [3]
In another study which was published from West Bengal, a state in Eastern India, has shown that 77.27% of people want to take the COVID-19 vaccine. [201] According to the finding from these two studies, it can be expected that over 75% of people want to get a COVID-19 vaccine.
Aarogya Setu (translation from Sanskrit: the bridge to health) is an Indian COVID-19 "contact tracing, syndromic mapping and self-assessment" digital service, primarily a mobile app, developed by the National Informatics Centre under the Ministry of Electronics and Information Technology (MeitY).